These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6656783)

  • 21. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
    Bhargava HN
    NIDA Res Monogr; 1984 Mar; 49():320-6. PubMed ID: 6148693
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding.
    Bean AJ; Elgin RJ; Cooper DM; Martin GE
    Peptides; 1987; 8(1):39-44. PubMed ID: 3575153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in spontaneously hypertensive rats.
    Bhargava HN
    Life Sci; 1983 May; 32(18):2131-7. PubMed ID: 6843287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN
    Life Sci; 1981 Nov; 29(19):1945-9. PubMed ID: 6118804
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    List SJ; Seeman P
    Life Sci; 1979 Apr; 24(16):1447-52. PubMed ID: 470544
    [No Abstract]   [Full Text] [Related]  

  • 28. Intragastric administration of cyclo(Leu-Gly) inhibits the development of tolerance to the analgesic effect of morphine in the rat.
    Bhargava HN
    Life Sci; 1988; 43(2):187-92. PubMed ID: 3393061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice.
    Ritzmann RF; Bhargava HN
    Life Sci; 1980 Dec; 27(22):2075-80. PubMed ID: 6782403
    [No Abstract]   [Full Text] [Related]  

  • 31. Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat.
    Bhargava HN
    Life Sci; 1980 Sep; 27(12):1075-81. PubMed ID: 6106875
    [No Abstract]   [Full Text] [Related]  

  • 32. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ; Boucher R; Daigle M; Di Paolo T
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic sulpiride on striatal spiperone binding.
    Bannet J; Gillis S; Ebstein RP; Belmaker RH
    Int Pharmacopsychiatry; 1980; 15(6):334-7. PubMed ID: 7298264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen in experimental tardive dyskinesia.
    Gordon JH; Borison RL; Diamond BI
    Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing.
    Fields JZ; Lee JM; Gordon JH; Wichlinski LJ; Ritzmann RF
    Neuropeptides; 1990 Aug; 16(4):207-11. PubMed ID: 2274115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of tardive dyskinesia: their use in the search for new treatment methods.
    Goetz CG; Klawans HL; Carvey P
    Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633
    [No Abstract]   [Full Text] [Related]  

  • 37. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN
    Life Sci; 1981 Jul; 29(1):45-51. PubMed ID: 6115301
    [No Abstract]   [Full Text] [Related]  

  • 39. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH; Hess V; Flohé L
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.